Section Arrow
PHAR.NASDAQ
- Pharming Group NV
Quotes are at least 15-min delayed:2026/01/07 03:39 EST
Regular Hours
Last
 16.86
+0.05 (+0.30%)
Day High 
17.05 
Prev. Close
16.81 
1-M High
18.2952 
Volume 
25.67K 
Bid
--
Ask
--
Day Low
16.55 
Open
16.91 
1-M Low
16.15 
Market Cap 
1.17B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 17.28 
20-SMA 17.13 
50-SMA 16.16 
52-W High 18.2952 
52-W Low 7.5018 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
--/0.46
Enterprise Value
1.28B
Balance Sheet
Book Value Per Share
3.80
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
10.83M
Operating Revenue Per Share
3.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CYCNCyclerion Therapeutics1.95+0.57+41.30%-- 
ALMSAlumis Inc.16.23+7.92+95.31%0.33PE
MREOMereo BioPharma Group plc0.379-0.1016-21.14%-- 
SLSSELLAS Life Sciences Group4.1-0.9-18.00%-- 
RXRXRecursion Pharmaceuticals4.55+0.18+4.12%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib),a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.